参考指南:
- 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会 (CSCO) 小细胞肺癌诊疗指南2024. 人民卫生出版社. 北京 2024
- Wu YL,Planchard D, Lu S, et al. Pan-Asianadapted Clinical Practice Guidelines for the management of patients withmetastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO,KSMO, MOS, SSO and TOS. Annals of Oncology, 2019,30(2):171–210, https://doi.org/10.1093/annonc/mdy554.
- NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer. Version 1.2020
- ACCP. Diagnosis and Management of Lung Cancer,3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 2013
参考文献:
[1] MANAPOV F, KLÖCKING S, NIYAZI M, et al. Timing of failure in limited disease (stage Ⅰ -Ⅲ ) small-cell lung cancer patients treated with chemoradiotherapy: A retrospective analysis. Tumori, 2013, 99 (6): 656-660.
[2] JOHNSON BE, LINNOILA RI, WILLIAMS JP, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol, 1995, 13 (1): 101-111.
[3] JOHNSON BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst, 1998, 90 (18): 1335-1345.
[4] RICHARDSON GE, TUCKER MA, VENZON DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med, 1993, 119 (5): 383-390.
[5] KAWAHARA M, USHIJIMA S, KAMIMORI T, et al. Second primary tumours in more than 2-year disease-free sur- vivors of small-cell lung cancer in Japan: The role of smoking cessation. Br J Cancer, 1998, 78 (3): 409-412.
[6] PARSONS A, DALEY A, BEGH R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. BMJ, 2010, 340: b5569.
[7] 李兆沛 , 孟祥文 , 宋伟 . 支气管肺神经内分泌肿瘤 140 例特征及预后分析 . 河北医科大学学报 , 2012, 33 (3): 304-305.
[8] CWIKłA JB, BUSCOMBE JR, CAPLIN ME, et al. Diagnostic imaging of carcinoid metastases to the abdomen and pelvis. Med Sci Monit, 2004, 10(Suppl 3): 9-16.
[9] KALTSAS G, ROCKALL A, PAPADOGIAS D, et al. Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol, 2004, 151 (1): 15-27.
[10] KAYANI I, CONRY BG, GROVES AM, et al. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmo- nary neuroendocrine tumors. J Nucl Med, 2009, 50 (12): 1927-1932.
[11] FOX DJ, KHATTAR RS. Carcinoid heart disease: Presentation, diagnosis, and management. Heart, 2004, 90 (10): 1224-1228.
更新:20240916
发表:20240916